These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS). Quaid KA; Eberly SW; Kayson-Rubin E; Oakes D; Shoulson I; Clin Genet; 2017 Jun; 91(6):824-831. PubMed ID: 27740685 [TBL] [Abstract][Full Text] [Related]
4. Phenotype-genotype discrepancies in the prospective Huntington at-risk observational study. Shoulson I; Eberly S; Oakes D; Kayson E; Young AB; Ann Clin Transl Neurol; 2019 Jun; 6(6):1046-1052. PubMed ID: 31211168 [TBL] [Abstract][Full Text] [Related]
5. Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants. Marder K; Zhao H; Eberly S; Tanner CM; Oakes D; Shoulson I; Neurology; 2009 Aug; 73(5):385-92. PubMed ID: 19652143 [TBL] [Abstract][Full Text] [Related]
6. Exploring the correlates of intermediate CAG repeats in Huntington disease. Ha AD; Jankovic J Postgrad Med; 2011 Sep; 123(5):116-21. PubMed ID: 21904093 [TBL] [Abstract][Full Text] [Related]
7. Suicidality in Huntington's Disease: A Qualitative Study on Coping Styles and Support Strategies. Hubers AA; Hamming A; Giltay EJ; von Faber M; Roos RA; van der Mast RC; van Duijn E J Huntingtons Dis; 2016 May; 5(2):185-98. PubMed ID: 27258585 [TBL] [Abstract][Full Text] [Related]
8. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients. Ribaï P; Nguyen K; Hahn-Barma V; Gourfinkel-An I; Vidailhet M; Legout A; Dodé C; Brice A; Dürr A Arch Neurol; 2007 Jun; 64(6):813-9. PubMed ID: 17562929 [TBL] [Abstract][Full Text] [Related]
9. Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease. Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Cassiman JJ; Cloostermans T; Demyttenaere K; Dom R; Fryns JP J Med Genet; 1999 Dec; 36(12):897-905. PubMed ID: 10593997 [TBL] [Abstract][Full Text] [Related]
10. Living at risk: concealing risk and preserving hope in Huntington disease. Quaid KA; Sims SL; Swenson MM; Harrison JM; Moskowitz C; Stepanov N; Suter GW; Westphal BJ J Genet Couns; 2008 Feb; 17(1):117-28. PubMed ID: 17943424 [TBL] [Abstract][Full Text] [Related]
11. To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington's disease. Robins Wahlin TB Patient Educ Couns; 2007 Mar; 65(3):279-87. PubMed ID: 17000074 [TBL] [Abstract][Full Text] [Related]
13. The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study. Anderson KE; Eberly S; Marder KS; Oakes D; Kayson E; Young A; Shoulson I; Clin Genet; 2019 Jul; 96(1):28-34. PubMed ID: 31093973 [TBL] [Abstract][Full Text] [Related]
14. Emotional and functional impact of DNA testing on patients with symptoms of Huntington's disease. Jankovic J; Beach J; Ashizawa T J Med Genet; 1995 Jul; 32(7):516-8. PubMed ID: 7562962 [TBL] [Abstract][Full Text] [Related]
15. At risk for Huntington disease: The PHAROS (Prospective Huntington At Risk Observational Study) cohort enrolled. Huntington Study Group PHAROS Investigators Arch Neurol; 2006 Jul; 63(7):991-6. PubMed ID: 16831969 [TBL] [Abstract][Full Text] [Related]
16. Genetic testing and mental health: the model of Huntington disease. Williams JK; Schutte DL Online J Issues Nurs; 2000; 5(3):3. PubMed ID: 11380269 [TBL] [Abstract][Full Text] [Related]
17. Ripples from a stone skipping across the lake: a narrative approach to the meaning of Huntington's disease. Schwartz RR J Neurosci Nurs; 2010 Jun; 42(3):157-68. PubMed ID: 20550076 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of molecular testing in Huntington's disease. Wang V; Yeh TP; Chen CM; Yan SH; Soong BW Zhonghua Yi Xue Za Zhi (Taipei); 1999 Sep; 62(9):586-90. PubMed ID: 10502848 [TBL] [Abstract][Full Text] [Related]
19. A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Almqvist EW; Bloch M; Brinkman R; Craufurd D; Hayden MR Am J Hum Genet; 1999 May; 64(5):1293-304. PubMed ID: 10205260 [TBL] [Abstract][Full Text] [Related]
20. Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study. Epping EA; Mills JA; Beglinger LJ; Fiedorowicz JG; Craufurd D; Smith MM; Groves M; Bijanki KR; Downing N; Williams JK; Long JD; Paulsen JS; J Psychiatr Res; 2013 Oct; 47(10):1423-31. PubMed ID: 23790259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]